Development of cyclopeptide inhibitors specifically disrupting FXR-coactivator interaction in the intestine as a novel therapeutic strategy for MASH.

發展特異性干擾腸道 FXR-共激活因子相互作用的環肽抑制劑，作為治療 MASH 的新策略。